This article addresses the measurement of the power spectrum of red noise processes at the lowest frequencies, where the minimum acquisition time is so long that it is impossible to average on a sequence of data record. Therefore, averaging is possible only on simultaneous observation of multiple instruments. This is the case of radio astronomy, which we take as the paradigm, but examples may be found in other fields such as climatology and geodesy. We compare the Bayesian confidence interval of the red noise parameter using two estimators, the spectrum average and the cross-spectrum. While the spectrum average is widely used, the cross-spectrum using multiple instruments is rather uncommon. With two instruments, the cross-spectrum estimator leads to the Variance-Gamma distribution. A generalization to q devices based on the Fourier transform of characteristic functions is provided, with the example of the observation of millisecond pulsars with five radio telescopes (RTs). The simulations show that the spectrum average is by a small amount more efficient than the cross-spectrum, chiefly when the background exceeds the signal. However, some notable differences between their upper limit indicate that it should be wiser to compute both estimators.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TUFFC.2022.3185528DOI Listing

Publication Analysis

Top Keywords

spectrum average
16
multiple instruments
12
cross-spectrum spectrum
8
red noise
8
average cross-spectrum
8
spectrum
5
average
5
statistics cross-spectrum
4
average generalization
4
generalization multiple
4

Similar Publications

Objective: This study aims to delineate the clinical features underlying the concurrent disease of neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG), and to identify efficacious therapeutic strategies.

Background: NMOSD and MG are uncommon autoimmune diseases that infrequently co-exist. Despite previous reports, a consensus on treating NMOSD concurrent with MG is lacking.

View Article and Find Full Text PDF

New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024.

Acta Pharmacol Sin

January 2025

Department of Medical Microbiology & Parasitology, MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University Shanghai Medical College, Shanghai, 200032, China.

Metabolic dysfunction-associated steatotic liver disease (MASLD) covers a broad spectrum of profile from simple fatty liver, evolving to metabolic dysfunction-associated steatohepatitis (MASH), to hepatic fibrosis, further progressing to cirrhosis and hepatocellular carcinoma (HCC). MASLD has become a prevalent disease with 25% in average over the world. MASH is an active stage, and requires pharmacological intervention when there is necroptotic damage with fibrotic progression.

View Article and Find Full Text PDF

The mutant waxy allele (wx1) is responsible for increased amylopectin in maize starch, with a wide range of food and industrial applications. The amino acid profile of waxy maize resembles normal maize, making it particularly deficient in lysine and tryptophan. Therefore, the present study explored the combined effects of genes governing carbohydrate and protein composition on nutritional profile and kernel physical properties by crossing Quality Protein Maize (QPM) (o2o2/wx1wx1) and waxy (o2o2/wx1wx1) parents.

View Article and Find Full Text PDF

Long-term surgical outcomes of esotropic duane retraction syndrome type 1.

Sci Rep

January 2025

Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam, 13620, Gyeonggi-do, Republic of Korea.

Duane retraction syndrome (DRS) is complicated to treat due to its wide spectrum of clinical presentations and the treatment of choice varies among surgeons. To provide insight into this challenging condition, we evaluated the long-term surgical outcomes of esotropic DRS type 1. The surgical motor success, defined as a horizontal deviation of 8 prism diopters (PD) or less, was found in 77.

View Article and Find Full Text PDF

Hexahistidine-metal assembly encapsulated fibroblast growth factor 21 for lipopolysaccharide-induced acute lung injury.

Eur J Pharm Biopharm

January 2025

Intervention Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China. Electronic address:

Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) represents a spectrum of potentially fatal conditions that currently lack effective drug treatment. Recent researches suggest that Fibroblast Growth Factor 21 (FGF21) may protect against ALI/ARDS. However, the clinical use of FGF21 is limited by its rapid degradation, restricted targeting capabilities, and numerous adverse effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!